A GUIDE TO UNDERSTANDING & SUPPORT

Posterior reversible encephalopathy syndrome (PRES)

PRES combines a clinical illness with characteristic brain-imaging findings. Despite the name, changes are not always confined to the posterior brain and are not guaranteed to reverse completely.

PRES is an acute brain syndrome that can affect vision, awareness and seizures.

Sources checked 24 Oct 2026Clinical review pendingEditorial sources
Explore the visual example
When a change needs assessment Sudden visual loss or visual change with a seizure, severe headache, confusion or reduced responsiveness needs emergency assessment. In pregnancy or after birth, new visual symptoms with headache or illness also need urgent care; do not wait to measure a particular blood-pressure value at home. [1] [2]
UNDERSTAND THE VISUAL PROBLEM

How the pieces fit together

Original teaching diagram

A static filter cannot represent acute brain edema, altered awareness or seizure risk. [1] [2]

Clinical illness, brain edema and visual function

Original educational schematic; it does not diagnose, predict an individual outcome or reproduce a patient’s perception. [1] [2]

Original VisualSim teaching diagram · © VisualSim. Clinical basis in linked sources; not a published study figure. Image provenance.
  1. Clinical pattern

    Acute visual and neurological changes raise several possible diagnoses.

  2. Assessment

    Clinical assessment and imaging distinguish edema and complications.

  3. Support

    Treat the cause and reassess residual visual and cognitive needs.

Use this visual explanation alongside the symptom descriptions, assessment information and practical resources below.

01 / THE QUICK EXPLANATION

Understanding Posterior reversible encephalopathy syndrome (PRES)

Visual disturbance can range from blur or field loss to profound cerebral visual impairment. Headache, seizures and altered mental state may accompany it, but not every person has the same combination. PRES is a clinical-and-imaging diagnosis, not a label that a screen effect can establish. [1] [2]

Associated contexts include major blood-pressure change, pregnancy-related illness, renal disease and certain medications or immune treatments. A clinician must assess the actual circumstances; the presence of an associated condition does not mean PRES is inevitable. [1] [3]

02 / WHAT PEOPLE MAY EXPERIENCE

One condition. Different experiences.

03 / WHAT WE KNOW

What is happening—and what remains uncertain

Blood–brain barrier and endothelial dysfunction are central models for the development of brain edema in PRES. Blood-pressure regulation, inflammatory or toxic mechanisms and the underlying illness can interact. [1] [3]

Imaging often identifies vasogenic edema in posterior regions, yet distribution and complications vary. Distinguishing edema from infarction, hemorrhage or another process matters for treatment and prognosis. [1] [2]

04 / MAKING DISTINCTIONS

What can look similar?

Stroke

Acute field or visual loss can be vascular or another emergency. Similar symptoms do not permit a home distinction between stroke and PRES. [1] [2]

Migraine aura

A familiar transient aura is not the same as new visual symptoms with encephalopathy or seizures; an unusual episode needs assessment. [1] [2]

The name versus the disease

Posterior and reversible describe a common pattern, not mandatory anatomy or a guaranteed outcome. [1] [3]

Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.

05 / GETTING AN ASSESSMENT

What an assessment may involve

  1. Urgent clinical assessmentThe team evaluates neurological state, seizures, blood pressure and systemic illness together rather than treating vision in isolation. [1] [2]
  2. Brain imaging and differential diagnosisMRI commonly supports diagnosis and helps assess edema and complications; the clinical context remains essential. [1] [2]
  3. Search for contributing factorsMedication exposure, kidney function, pregnancy-related illness and other relevant causes are reviewed to guide individualized care. [1] [3]
06 / CARE AND UNCERTAINTY

What may help—and what is still being studied

Treat the precipitating illness

Management targets the identified cause and associated physiological problems within acute medical care. This page provides no home blood-pressure or medication regimen. [1] [2]

Manage seizures and complications

Treatment and monitoring depend on the clinical presentation, with reassessment if symptoms change. [1] [2]

Plan follow-up by function

Imaging improvement does not alone establish recovered vision or cognition. Persistent difficulty can need eye, neurological and rehabilitation review. [1] [3]

07 / DAILY LIFE

What this can mean for daily life

Obtain a clear discharge plan

Ask which symptoms require return and who follows the neurological and precipitating condition. [1] [2]

Describe residual vision

Report field, reading, recognition or glare problems separately so rehabilitation addresses the actual deficit. [1] [3]

Review medicines with the team

Do not stop a potentially associated drug independently; its indication and alternatives require clinical judgment. [1] [3]

Reassess daily demands

Discuss driving, work, mobility and seizure-related restrictions with the treating team and relevant local services. [1] [2]

08 / YOUR NEXT CONVERSATION

Bring a clearer description to your appointment

Choose the questions you want to discuss. These choices stay in this page’s memory.

09 / LOOK CLOSER

Research, with the context left in

Selected studies and guidance, with their populations and limitations. These are curated educational summaries, not a complete systematic review or a formal evidence rating.

2021 · Narrative clinical review.

Posterior Reversible Encephalopathy Syndrome

Explains variable neurological presentations and major associated contexts. [1]

Limits and applicability: Observational literature does not establish one uniform mechanism, recovery rate or treatment protocol.

2025 · Clinical review in The Lancet Neurology.

Posterior reversible encephalopathy syndrome: evolving insights in diagnosis, management, and outcomes

Updates the spectrum of presentations, endothelial mechanisms and treatment-associated contexts. [3]

Limits and applicability: Biomarker possibilities and mechanistic models are not established individual prediction tools.

2022 · Practical clinical review.

Posterior reversible encephalopathy syndrome: diagnosis and management

Emphasizes clinical context and MRI-supported diagnosis with management of contributing illness. [2]

Limits and applicability: Review guidance is not randomized comparative evidence for every acute management decision.

Questions researchers still need to answer
  • Which markers predict persistent visual or cognitive disability?
  • Which management strategies improve patient-important outcomes in specific precipitating illnesses?
10 / KEEP LEARNING

Trusted places to go next

Selected clinical references, research, practical support and ways to connect. Official pages checked 24 October 2026; each entry explains its scope and region.

Research · Public online education; local clinical services have their own access requirements.

PRES — open clinical review

Clinical background on presentations, causes and limitations.

Clinical education · Public online education; local clinical services have their own access requirements.

Practical Neurology — PRES diagnosis and management

Specialist clinical review; reading access may vary.

Clinical education · Public online education; local clinical services have their own access requirements.

StatPearls — PRES

Clinical reference to support questions for the treating team.

11 / COMMON QUESTIONS

Questions you may still have

Is complete recovery guaranteed?

No. Many cases improve, but persistent impairment and complications can occur. [1] [3]

Must the changes be only at the back of the brain?

No. The imaging distribution can extend beyond posterior regions. [1] [3]

Can vision be affected without an eye problem explaining it?

Yes. Brain-based visual dysfunction can contribute, but a full clinical evaluation remains necessary. [1] [2]

Should I stop a suspected medication?

Medication decisions belong to the treating team; an association is not proof that a particular drug caused an individual episode. [1] [3]

12 / TRANSPARENCY

Sources, image credits and review status

Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.

  1. Gewirtz et al. — Posterior Reversible Encephalopathy Syndrome (2021; review).

    Europe PMC full XML read.

    Checked 2026-10-24 · Full text checked
  2. Posterior reversible encephalopathy syndrome: diagnosis and management (2022; review).

    Official article/PDF indexed clinical summary checked.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  3. Posterior reversible encephalopathy syndrome: evolving insights in diagnosis, management, and outcomes (2025; review).

    Official publisher summary checked.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  4. Posterior Reversible Encephalopathy Syndrome — StatPearls (2026; review).

    Official current indexed clinical summary checked.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  5. Posterior Reversible Encephalopathy Syndrome — NEJM (2023; review).

    Official indexed review summary checked; full article access not assumed.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed

The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.

Enlarged figure